Global Anorexiants Market Size, Status and Forecast 2020-2026

August 2020 | 94 pages | ID: G002C6805CF2EN
QYResearch

Abstracts

This report focuses on the global Anorexiants status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Anorexiants development in North America, Europe and Asia-Pacific.
The key players covered in this study

• Akrimax Pharmaceuticals
• Teva
• Johnson & Johnson
• Roche
• Arena Pharmaceuticals
• Novo Nordisk
• Abbott
• Epic Pharma
• Recordati Rare Diseases

Market segment by Type, the product can be split into

• Oral Anorexiants
• Subcutaneous Anorexiants

Market segment by Application, split into

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

Market segment by Regions/Countries, this report covers

• North America
• Europe
• Asia-Pacific

The study objectives of this report are:

• To analyze global Anorexiants status, future forecast, growth opportunity, key market and key players.
• To present the Anorexiants development in North America, Europe and Asia-Pacific.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Anorexiants are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Anorexiants Revenue
1.4 Market Analysis by Type
  1.4.1 Global Anorexiants Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Oral Anorexiants
  1.4.3 Subcutaneous Anorexiants
1.5 Market by Application
  1.5.1 Global Anorexiants Market Share by Application: 2020 VS 2026
  1.5.2 Hospital Pharmacy
  1.5.3 Retail Pharmacy
  1.5.4 Online Pharmacy
1.6 Coronavirus Disease 2019 (Covid-19): Anorexiants Industry Impact
  1.6.1 How the Covid-19 is Affecting the Anorexiants Industry
    1.6.1.1 Anorexiants Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Anorexiants Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Anorexiants Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Anorexiants Market Perspective (2015-2026)
2.2 Anorexiants Growth Trends by Regions
  2.2.1 Anorexiants Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Anorexiants Historic Market Share by Regions (2015-2020)
  2.2.3 Anorexiants Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Anorexiants Market Growth Strategy
  2.3.6 Primary Interviews with Key Anorexiants Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Anorexiants Players by Market Size
  3.1.1 Global Top Anorexiants Players by Revenue (2015-2020)
  3.1.2 Global Anorexiants Revenue Market Share by Players (2015-2020)
  3.1.3 Global Anorexiants Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Anorexiants Market Concentration Ratio
  3.2.1 Global Anorexiants Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Anorexiants Revenue in 2019
3.3 Anorexiants Key Players Head office and Area Served
3.4 Key Players Anorexiants Product Solution and Service
3.5 Date of Enter into Anorexiants Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Anorexiants Historic Market Size by Type (2015-2020)
4.2 Global Anorexiants Forecasted Market Size by Type (2021-2026)

5 ANOREXIANTS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Anorexiants Market Size by Application (2015-2020)
5.2 Global Anorexiants Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Anorexiants Market Size (2015-2020)
6.2 Anorexiants Key Players in North America (2019-2020)
6.3 North America Anorexiants Market Size by Type (2015-2020)
6.4 North America Anorexiants Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Anorexiants Market Size (2015-2020)
7.2 Anorexiants Key Players in Europe (2019-2020)
7.3 Europe Anorexiants Market Size by Type (2015-2020)
7.4 Europe Anorexiants Market Size by Application (2015-2020)

8 ASIA-PACIFIC

8.1 Asia-Pacific Anorexiants Market Size (2015-2020)
8.2 Anorexiants Key Players in Asia-Pacific (2019-2020)
8.3 Asia-Pacific Anorexiants Market Size by Type (2015-2020)
8.4 Asia-Pacific Anorexiants Market Size by Application (2015-2020)
(2015-2020)
(2015-2020)

9 KEY PLAYERS PROFILES

9.1 Akrimax Pharmaceuticals
  9.1.1 Akrimax Pharmaceuticals Company Details
  9.1.2 Akrimax Pharmaceuticals Business Overview and Its Total Revenue
  9.1.3 Akrimax Pharmaceuticals Anorexiants Introduction
  9.1.4 Akrimax Pharmaceuticals Revenue in Anorexiants Business (2015-2020))
  9.1.5 Akrimax Pharmaceuticals Recent Development
9.2 Teva
  9.2.1 Teva Company Details
  9.2.2 Teva Business Overview and Its Total Revenue
  9.2.3 Teva Anorexiants Introduction
  9.2.4 Teva Revenue in Anorexiants Business (2015-2020)
  9.2.5 Teva Recent Development
9.3 Johnson & Johnson
  9.3.1 Johnson & Johnson Company Details
  9.3.2 Johnson & Johnson Business Overview and Its Total Revenue
  9.3.3 Johnson & Johnson Anorexiants Introduction
  9.3.4 Johnson & Johnson Revenue in Anorexiants Business (2015-2020)
  9.3.5 Johnson & Johnson Recent Development
9.4 Roche
  9.4.1 Roche Company Details
  9.4.2 Roche Business Overview and Its Total Revenue
  9.4.3 Roche Anorexiants Introduction
  9.4.4 Roche Revenue in Anorexiants Business (2015-2020)
  9.4.5 Roche Recent Development
9.5 Arena Pharmaceuticals
  9.5.1 Arena Pharmaceuticals Company Details
  9.5.2 Arena Pharmaceuticals Business Overview and Its Total Revenue
  9.5.3 Arena Pharmaceuticals Anorexiants Introduction
  9.5.4 Arena Pharmaceuticals Revenue in Anorexiants Business (2015-2020)
  9.5.5 Arena Pharmaceuticals Recent Development
9.6 Novo Nordisk
  9.6.1 Novo Nordisk Company Details
  9.6.2 Novo Nordisk Business Overview and Its Total Revenue
  9.6.3 Novo Nordisk Anorexiants Introduction
  9.6.4 Novo Nordisk Revenue in Anorexiants Business (2015-2020)
  9.6.5 Novo Nordisk Recent Development
9.7 Abbott
  9.7.1 Abbott Company Details
  9.7.2 Abbott Business Overview and Its Total Revenue
  9.7.3 Abbott Anorexiants Introduction
  9.7.4 Abbott Revenue in Anorexiants Business (2015-2020)
  9.7.5 Abbott Recent Development
9.8 Epic Pharma
  9.8.1 Epic Pharma Company Details
  9.8.2 Epic Pharma Business Overview and Its Total Revenue
  9.8.3 Epic Pharma Anorexiants Introduction
  9.8.4 Epic Pharma Revenue in Anorexiants Business (2015-2020)
  9.8.5 Epic Pharma Recent Development
9.9 Recordati Rare Diseases
  9.9.1 Recordati Rare Diseases Company Details
  9.9.2 Recordati Rare Diseases Business Overview and Its Total Revenue
  9.9.3 Recordati Rare Diseases Anorexiants Introduction
  9.9.4 Recordati Rare Diseases Revenue in Anorexiants Business (2015-2020)
  9.9.5 Recordati Rare Diseases Recent Development

10 ANALYST'S VIEWPOINTS/CONCLUSIONS

11 APPENDIX

11.1 Research Methodology
  11.1.1 Methodology/Research Approach
  11.1.2 Data Source
11.2 Disclaimer
11.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Anorexiants Key Market Segments
Table 2. Key Players Covered: Ranking by Anorexiants Revenue
Table 3. Ranking of Global Top Anorexiants Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Anorexiants Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Oral Anorexiants
Table 6. Key Players of Subcutaneous Anorexiants
Table 7. COVID-19 Impact Global Market: (Four Anorexiants Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Anorexiants Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Anorexiants Players to Combat Covid-19 Impact
Table 12. Global Anorexiants Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Anorexiants Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Anorexiants Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Anorexiants Market Share by Regions (2015-2020)
Table 16. Global Anorexiants Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Anorexiants Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Anorexiants Market Growth Strategy
Table 22. Main Points Interviewed from Key Anorexiants Players
Table 23. Global Anorexiants Revenue by Players (2015-2020) (Million US$)
Table 24. Global Anorexiants Market Share by Players (2015-2020)
Table 25. Global Top Anorexiants Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anorexiants as of 2019)
Table 26. Global Anorexiants by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Anorexiants Product Solution and Service
Table 29. Date of Enter into Anorexiants Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Anorexiants Market Size by Type (2015-2020) (Million US$)
Table 32. Global Anorexiants Market Size Share by Type (2015-2020)
Table 33. Global Anorexiants Revenue Market Share by Type (2021-2026)
Table 34. Global Anorexiants Market Size Share by Application (2015-2020)
Table 35. Global Anorexiants Market Size by Application (2015-2020) (Million US$)
Table 36. Global Anorexiants Market Size Share by Application (2021-2026)
Table 37. North America Key Players Anorexiants Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Anorexiants Market Share (2019-2020)
Table 39. North America Anorexiants Market Size by Type (2015-2020) (Million US$)
Table 40. North America Anorexiants Market Share by Type (2015-2020)
Table 41. North America Anorexiants Market Size by Application (2015-2020) (Million US$)
Table 42. North America Anorexiants Market Share by Application (2015-2020)
Table 43. Europe Key Players Anorexiants Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Anorexiants Market Share (2019-2020)
Table 45. Europe Anorexiants Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Anorexiants Market Share by Type (2015-2020)
Table 47. Europe Anorexiants Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Anorexiants Market Share by Application (2015-2020)
Table 49. Asia-Pacific Key Players Anorexiants Revenue (2019-2020) (Million US$)
Table 50. Asia-Pacific Key Players Anorexiants Market Share (2019-2020)
Table 51. Asia-Pacific Anorexiants Market Size by Type (2015-2020) (Million US$)
Table 52. Asia-Pacific Anorexiants Market Share by Type (2015-2020)
Table 53. Asia-Pacific Anorexiants Market Size by Application (2015-2020) (Million US$)
Table 54. Asia-Pacific Anorexiants Market Share by Application (2015-2020)
Table 55. Akrimax Pharmaceuticals Company Details
Table 56. Akrimax Pharmaceuticals Business Overview
Table 57. Akrimax Pharmaceuticals Product
Table 58. Akrimax Pharmaceuticals Revenue in Anorexiants Business (2015-2020) (Million US$)
Table 59. Akrimax Pharmaceuticals Recent Development
Table 60. Teva Company Details
Table 61. Teva Business Overview
Table 62. Teva Product
Table 63. Teva Revenue in Anorexiants Business (2015-2020) (Million US$)
Table 64. Teva Recent Development
Table 65. Johnson & Johnson Company Details
Table 66. Johnson & Johnson Business Overview
Table 67. Johnson & Johnson Product
Table 68. Johnson & Johnson Revenue in Anorexiants Business (2015-2020) (Million US$)
Table 69. Johnson & Johnson Recent Development
Table 70. Roche Company Details
Table 71. Roche Business Overview
Table 72. Roche Product
Table 73. Roche Revenue in Anorexiants Business (2015-2020) (Million US$)
Table 74. Roche Recent Development
Table 75. Arena Pharmaceuticals Company Details
Table 76. Arena Pharmaceuticals Business Overview
Table 77. Arena Pharmaceuticals Product
Table 78. Arena Pharmaceuticals Revenue in Anorexiants Business (2015-2020) (Million US$)
Table 79. Arena Pharmaceuticals Recent Development
Table 80. Novo Nordisk Company Details
Table 81. Novo Nordisk Business Overview
Table 82. Novo Nordisk Product
Table 83. Novo Nordisk Revenue in Anorexiants Business (2015-2020) (Million US$)
Table 84. Novo Nordisk Recent Development
Table 85. Abbott Company Details
Table 86. Abbott Business Overview
Table 87. Abbott Product
Table 88. Abbott Revenue in Anorexiants Business (2015-2020) (Million US$)
Table 89. Abbott Recent Development
Table 90. Epic Pharma Business Overview
Table 91. Epic Pharma Product
Table 92. Epic Pharma Company Details
Table 93. Epic Pharma Revenue in Anorexiants Business (2015-2020) (Million US$)
Table 94. Epic Pharma Recent Development
Table 95. Recordati Rare Diseases Company Details
Table 96. Recordati Rare Diseases Business Overview
Table 97. Recordati Rare Diseases Product
Table 98. Recordati Rare Diseases Revenue in Anorexiants Business (2015-2020) (Million US$)
Table 99. Recordati Rare Diseases Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Anorexiants Market Share by Type: 2020 VS 2026
Figure 2. Oral Anorexiants Features
Figure 3. Subcutaneous Anorexiants Features
Figure 4. Global Anorexiants Market Share by Application: 2020 VS 2026
Figure 5. Hospital Pharmacy Case Studies
Figure 6. Retail Pharmacy Case Studies
Figure 7. Online Pharmacy Case Studies
Figure 8. Anorexiants Report Years Considered
Figure 9. Global Anorexiants Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Anorexiants Market Share by Regions: 2020 VS 2026
Figure 11. Global Anorexiants Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Anorexiants Market Share by Players in 2019
Figure 14. Global Top Anorexiants Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anorexiants as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Anorexiants Revenue in 2019
Figure 16. North America Anorexiants Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Anorexiants Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Asia-Pacific Anorexiants Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Akrimax Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 20. Akrimax Pharmaceuticals Revenue Growth Rate in Anorexiants Business (2015-2020)
Figure 21. Teva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 22. Teva Revenue Growth Rate in Anorexiants Business (2015-2020)
Figure 23. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Johnson & Johnson Revenue Growth Rate in Anorexiants Business (2015-2020)
Figure 25. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Roche Revenue Growth Rate in Anorexiants Business (2015-2020)
Figure 27. Arena Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Arena Pharmaceuticals Revenue Growth Rate in Anorexiants Business (2015-2020)
Figure 29. Novo Nordisk Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Novo Nordisk Revenue Growth Rate in Anorexiants Business (2015-2020)
Figure 31. Abbott Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Abbott Revenue Growth Rate in Anorexiants Business (2015-2020)
Figure 33. Epic Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Epic Pharma Revenue Growth Rate in Anorexiants Business (2015-2020)
Figure 35. Recordati Rare Diseases Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Recordati Rare Diseases Revenue Growth Rate in Anorexiants Business (2015-2020)
Figure 37. Bottom-up and Top-down Approaches for This Report
Figure 38. Data Triangulation
Figure 39. Key Executives Interviewed